[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.172.195.82. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 28, 1926

RADON (RADIUM EMANATION) AS A PALLIATIVE AGENT IN THE TREATMENT OF INTRA-ORAL CANCER

JAMA. 1926;87(9):655-657. doi:10.1001/jama.1926.02680090033011
Abstract

In intra-oral cancer, when should the primary lesion be submitted to surgery and when to irradiation? Evidently the operable lesions may be excised and the inoperable ones should receive irradiation. The greatest difference of opinion exists, however, as to what cases are really operable and what are inoperable. Judd and New1 of the Mayo Clinic rightly state that the statistics of the operative treatment of intra-oral cancer will depend largely on what one considers operable and inoperable. Some take the position that in dealing with the primary lesion in intra-oral cancer, surgery has no place at all. Others take a diametrically opposite view and believe that only in the hopelessly advanced cases should irradiation be done, and that in all other cases operation should be performed. Our position is that distinctly operable cases may receive the benefits of surgery, and all other cases should be treated with radon.

What

×